Checkpoint Capital L.P. has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $196 Billion distributed in 16 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Argenx Se with a value of $56.9B, Rhythm Pharmaceuticals, Inc. with a value of $40.8B, Phathom Pharmaceuticals, Inc. with a value of $18.5B, Axsome Therapeutics, Inc. with a value of $14.8B, and Disc Medicine Inc with a value of $11.7B.

Examining the 13F form we can see an decrease of $5.09B in the current position value, from $202B to 196B.

Checkpoint Capital L.P. is based out at San Francisco, CA

Below you can find more details about Checkpoint Capital L.P. portfolio as well as his latest detailed transactions.

Portfolio value $196 Billion
Healthcare: $166 Billion

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 16
  • Current Value $196 Billion
  • Prior Value $202 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 2 stocks
  • Additional Purchases 9 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Checkpoint Capital L.P. Portfolio

Follow Checkpoint Capital L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Checkpoint Capital L.P., based on Form 13F filings with the SEC.

News

Stay updated on Checkpoint Capital L.P. with notifications on news.